PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 20 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

7 February 2026

  1. (diff | hist) m 09:48 GenScript Peptides 15,252 ±0 BlankVialBo (talk | contribs) expand §Notability and coverage [rollback]
  2. (diff | hist) 09:22 Residual solvent 5,085 ±0 AnalyticalAnnie (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  3. (diff | hist) m 09:19 Area percent purity 8,537 ±0 NewLabNell (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  4. (diff | hist) 01:36 Sangon Biotech 14,764 ±0 ToleranceTove (talk | contribs) rm the price; supplier articles carry no price per PP:VN [rollback]

6 February 2026

  1. (diff | hist) 21:05 AmbioPharm 14,619 +1,173 AnaesthesiaAoife (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  2. (diff | hist) 20:54 Repackaging 4,759 ±0 SupplyWatchSuri (talk | contribs) rm the blanket claim that excursions are harmless [rollback]
  3. (diff | hist) 17:54 Drug master file 4,325 ±0 PuffRemoverPax (talk | contribs) clarify that personal importation and commercial importation are different questions [rollback]
  4. (diff | hist) 14:58 Talk:Vial 1,022 +368 StopperingSteff (talk | contribs) /* Polymer containers deserve more than a paragraph */ reply
  5. (diff | hist) 13:20 Talk:Adverse effects of GLP-1 receptor agonists 611 +117 ForestPlotFinn (talk | contribs) /* Placebo-arm nausea */ reply
  6. (diff | hist) 13:15 Talk:Gastric emptying 611 +121 AnalyticalAnnie (talk | contribs) /* Method comparability */ reply
  7. (diff | hist) 12:20 Talk:Liraglutide 885 +130 NeutralNikolai (talk | contribs) /* Should the article say liraglutide is obsolete? */ reply
  8. (diff | hist) 11:36 Talk:Vial 811 +307 API_Aurora (talk | contribs) /* Polymer containers deserve more than a paragraph */ new section
  9. (diff | hist) 10:48 Talk:Beyond-use date 1,244 +241 NPOV_Nadia (talk | contribs) /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
  10. (diff | hist) 10:40 Sigma-Aldrich (Shanghai) Trading 18,421 ±0 ChainCustodyChad (talk | contribs) state what the certificate supplied with orders carries [rollback]
  11. (diff | hist) 09:56 Trial data comparison 7,303 ±0 EpitalonEoin (talk | contribs) expand §How this page calculates so the formula is visible [rollback]
  12. (diff | hist) 09:50 Talk:Liraglutide 674 +153 PuffRemoverPax (talk | contribs) /* Should the article say liraglutide is obsolete? */ new section
  13. (diff | hist) 09:45 Talk:Adverse effects of GLP-1 receptor agonists 400 +161 NauseaNoor (talk | contribs) /* Placebo-arm nausea */ new section
  14. (diff | hist) 09:30 Talk:Gastric emptying 400 +193 EmptyingElke (talk | contribs) /* Method comparability */ new section
  15. (diff | hist) m 08:52 Sterile water for injection 4,738 ±0 Chromatokid (talk | contribs) add the cross-link to the calculator page [rollback]
  16. (diff | hist) m 03:07 Qingdao Sigma Chemical 15,455 ±0 FmocFrancis (talk | contribs) add the standing talk-page note link to the banner [rollback]
  17. (diff | hist) m b 01:42 Xi'an Mokemei Biotechnology 15,421 +220 CiteBot (talk | contribs) bot: mark outbound storefront link nofollow [rollback]

5 February 2026

  1. (diff | hist) m 20:13 Number needed to treat 4,718 ±0 SurpassSunniva (talk | contribs) flag the pooled analysis as post hoc [rollback]
  2. (diff | hist) 19:16 Tianjin Finder Chemical 14,449 ±0 Chromatokid (talk | contribs) label the reception tally as weak, self-selected evidence at this point of use [rollback]
  3. (diff | hist) 18:51 Peptide synthesis 5,649 ±0 MassSpecMarv (talk | contribs) clarify that "cold chain" without a logger is a claim, not a record [rollback]
  4. (diff | hist) 13:15 Talk:Peptide synthesis 611 +164 CrudePeptidePearl (talk | contribs) /* The yield arithmetic */ reply
  5. (diff | hist) 11:21 Fmoc chemistry 4,618 ±0 PriorAuthPaz (talk | contribs) rm a duplicated category [rollback]
  6. (diff | hist) m 11:09 Shanghai Sigma-Audley New Material Technology 15,579 +220 BPC_Bramwell (talk | contribs) correct the regional-warehouse list — six sites, not five [rollback]
  7. (diff | hist) 10:56 Talk:Karl Fischer titration 959 +102 Chromatokid (talk | contribs) /* Cysteine interference needs a source */ reply
  8. (diff | hist) m 10:55 Semaglutide 10,355 ±0 LiraLotte (talk | contribs) sentence case in headings per PP:MOS [rollback]
  9. (diff | hist) 09:40 Talk:Peptide synthesis 400 +177 SPPS_Sorrel (talk | contribs) /* The yield arithmetic */ new section
  10. (diff | hist) m 08:55 Deamidation 5,263 ±0 CustomsClarke (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]
  11. (diff | hist) 08:55 Talk:GLP-1 receptor agonist 822 +157 HalfLifeHavel (talk | contribs) /* Half-life table: are the figures comparable? */ reply

4 February 2026

  1. (diff | hist) m 15:49 Custom peptide synthesis 4,773 ±0 CounterfeitCato (talk | contribs) add the reconstitution-stability sentence with its storage condition [rollback]
  2. (diff | hist) 13:40 Talk:GLP-1 receptor agonist 611 +209 MolarMassMaeve (talk | contribs) /* Half-life table: are the figures comparable? */ reply
  3. (diff | hist) 13:30 Talk:Good manufacturing practice 611 +112 Compounding_Cate (talk | contribs) /* Regulators do not issue perpetual certificates */ reply
  4. (diff | hist) 13:15 Talk:MOTS-c 611 +107 PrimarySrcPatia (talk | contribs) /* Preclinical to human gap */ reply
  5. (diff | hist) 11:33 Liraglutide 5,967 ±0 TimelineTiernan (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  6. (diff | hist) 11:02 Talk:Beyond-use date 1,033 +294 LabelLibby (talk | contribs) /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
  7. (diff | hist) 09:55 Talk:Good manufacturing practice 400 +167 GMP_Gita (talk | contribs) /* Regulators do not issue perpetual certificates */ new section
  8. (diff | hist) 09:40 Talk:MOTS-c 400 +183 MOTSc_Mira (talk | contribs) /* Preclinical to human gap */ new section
  9. (diff | hist) 09:12 Talk:GLP-1 receptor agonist 400 +256 HalfLifeHavel (talk | contribs) /* Half-life table: are the figures comparable? */ new section
  10. (diff | hist) 08:19 Talk:Karl Fischer titration 748 +185 KarlFischerKit (talk | contribs) /* Cysteine interference needs a source */ reply
  11. (diff | hist) 06:58 Reconstitution of lyophilised peptides 5,761 ±0 RotationRosalind (talk | contribs) add the shelf life after first puncture, attributed [rollback]
  12. (diff | hist) 00:18 Janoshik Analytical 5,235 ±0 AnalyticalAnnie (talk | contribs) convert the service comparison to a table [rollback]

3 February 2026

  1. (diff | hist) 16:28 Baseline laboratory panel 4,429 ±0 BaselineBex (talk | contribs) expand §Common components [rollback]
  2. (diff | hist) 15:44 Talk:Karl Fischer titration 537 +373 CitationChaser (talk | contribs) /* Cysteine interference needs a source */ new section
  3. (diff | hist) 13:20 Talk:Haemoglobin A1c 611 +103 LabRangeLindy (talk | contribs) /* Weighting towards recent weeks */ reply
  4. (diff | hist) 13:20 Talk:Lot traceability 611 +142 GMP_Gita (talk | contribs) /* A lot is a procedural object */ reply
  5. (diff | hist) 11:33 Zhuhai Kerui Biotechnology 14,491 +1,086 ChainCustodyChad (talk | contribs) attribute the capability claim to the organisation's own material [rollback]
  6. (diff | hist) 10:20 Third-party testing 7,489 ±0 PurityClaimPia (talk | contribs) expand §Sampling and representativeness [rollback]
  7. (diff | hist) 10:00 Sterility testing 4,776 ±0 AAA_Analyst (talk | contribs) clarify that mass spectrometry confirms identity, not purity [rollback]
  8. (diff | hist) 09:45 Talk:Haemoglobin A1c 400 +129 A1c_Alder (talk | contribs) /* Weighting towards recent weeks */ new section
  9. (diff | hist) 09:45 Talk:Lot traceability 400 +219 LotTraceLuka (talk | contribs) /* A lot is a procedural object */ new section
  10. (diff | hist) 09:14 Talk:Beyond-use date 822 +388 Compounding_Cate (talk | contribs) /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply

2 February 2026

  1. (diff | hist) 21:56 Cold-chain freight 4,758 ±0 CustomsClarke (talk | contribs) give the vial sizes in millilitres of nominal capacity [rollback]
  2. (diff | hist) 20:00 Proglucagon 6,709 ±0 GsCouplingGil (talk | contribs) rm the causal claim about appetite — the cited work is associative [rollback]
  3. (diff | hist) m 14:45 SELECT trial 5,171 ±0 SelectTrialSam (talk | contribs) add category for the trial programme [rollback]
  4. (diff | hist) 14:00 Placebo-adjusted effect 4,805 ±0 KPV_Kester (talk | contribs) expand §How figures are misreported [rollback]
  5. (diff | hist) 12:31 Talk:Beyond-use date 611 +369 BUD_Bertram (talk | contribs) /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
  6. (diff | hist) 10:00 Talk:Beyond-use date 400 +671 RfC_Rasmus (talk | contribs) /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ new section

1 February 2026

  1. (diff | hist) m b 16:27 Oral semaglutide 4,582 ±0 CiteBot (talk | contribs) bot: repair redlinked category [rollback]
  2. (diff | hist) 13:53 Personal importation policy 4,121 ±0 Chromatokid (talk | contribs) convert a hard-coded date to the house format [rollback]
  3. (diff | hist) 13:30 Talk:Sterility testing 611 +193 EndotoxinEd (talk | contribs) /* The detection-probability table */ reply
  4. (diff | hist) 09:55 Talk:Sterility testing 400 +112 PlainNumbersPip (talk | contribs) /* The detection-probability table */ new section
  5. (diff | hist) 08:13 Melanotan II 4,649 ±0 Peptide_Pete (talk | contribs) add the impurity profile typical of solid-phase synthesis of this sequence [rollback]
  6. (diff | hist) 07:42 Insulin secretion 6,940 ±0 Ref_Desk_Ron (talk | contribs) expand §Amplifying pathways [rollback]
  7. (diff | hist) 07:12 SUSTAIN trial programme 5,153 ±0 FmocFrancis (talk | contribs) correct the endpoint hierarchy — that was a secondary endpoint [rollback]
  8. (diff | hist) 06:04 Glucose-dependent insulinotropic polypeptide 8,265 ±0 Hedgerow_Hal (talk | contribs) split §Physiology from §Pharmacological exploitation [rollback]
  9. (diff | hist) 04:34 Wuhan Wansheng Biotechnology 15,849 ±0 LotTraceLuka (talk | contribs) state what the certificate supplied with orders carries [rollback]
  10. (diff | hist) 02:39 Vial 26,012 +66 FmocFrancis (talk | contribs) correct the humidity figure — relative humidity needs its temperature [rollback]
  11. (diff | hist) m 01:22 Shenzhen Hybio Pharmaceutical 15,328 ±0 CPeptidePaddy (talk | contribs) add the outbound storefront link, marked nofollow and sponsored per the external-links convention [rollback]

31 January 2026

  1. (diff | hist) m b 23:46 Dipeptidyl peptidase-4 7,022 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) 13:59 Peptide supply chain 8,410 ±0 ForgeryFinder (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  3. (diff | hist) 13:34 Bacterial endotoxin test 5,317 ±0 EpitalonEoin (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  4. (diff | hist) 13:25 Talk:Insulin syringe 611 +121 UnitsUrsula (talk | contribs) /* Table is arithmetic, not guidance */ reply
  5. (diff | hist) m b 10:15 Grey market 4,279 ±0 StubSorterBot (talk | contribs) bot: update parent category chain [rollback]
  6. (diff | hist) 09:50 Talk:Insulin syringe 400 +203 NPOV_Nadia (talk | contribs) /* Table is arithmetic, not guidance */ new section
  7. (diff | hist) m b 09:29 Sarcopenia 4,491 ±0 CiteBot (talk | contribs) bot: add stub category [rollback]
  8. (diff | hist) m 06:29 Medutest 5,018 ±0 NauseaNoor (talk | contribs) label the community tally as self-reported at this point of use as well [rollback]

30 January 2026

  1. (diff | hist) 19:26 Chain of custody 5,157 ±0 Chromatokid (talk | contribs) state the method the reporting service uses, since it is not the only one available [rollback]
  2. (diff | hist) 19:11 GenScript Peptides 15,252 +964 ApoB_Aurelio (talk | contribs) expand §Operations and documentation practice [rollback]
  3. (diff | hist) 18:00 Dose escalation schedule 4,993 ±0 SyringeSybille (talk | contribs) correct the needle gauge given for subcutaneous administration [rollback]
  4. (diff | hist) m 17:03 Bachem Holding (Suzhou) 15,124 ±0 LotTraceLuka (talk | contribs) close an unbalanced quotation mark [rollback]
  5. (diff | hist) 16:51 Exenatide 5,754 ±0 EscalationEira (talk | contribs) move a stray full stop inside the reference [rollback]
  6. (diff | hist) m 14:36 USP General Chapter 71 4,657 ±0 PeakShapePol (talk | contribs) fix a broken wikilink [rollback]
  7. (diff | hist) 14:02 Talk:Dipeptidyl peptidase-4 748 +159 Chromatokid (talk | contribs) /* Assay caveat should be more prominent */ reply
  8. (diff | hist) 13:35 Talk:VendorInvestigate 611 +135 CrossRefCleve (talk | contribs) /* The answering table */ reply
  9. (diff | hist) 13:25 Talk:Weight regain after discontinuation 611 +133 NPOV_Nadia (talk | contribs) /* Lifelong treatment claim */ reply
  10. (diff | hist) 13:14 Glossary of peptide terminology 4,744 ±0 KPV_Kester (talk | contribs) rm an entry that does not meet the stated inclusion criterion [rollback]
  11. (diff | hist) 10:25 List of GLP-1 receptor agonists 3,862 ±0 NavboxNiko (talk | contribs) add the year of first description to each glossary term where known [rollback]
  12. (diff | hist) 10:15 Talk:Dipeptidyl peptidase-4 537 +197 AnalyticalAnnie (talk | contribs) /* Assay caveat should be more prominent */ new section
  13. (diff | hist) 10:05 Talk:VendorInvestigate 400 +215 VerifyVesna (talk | contribs) /* The answering table */ new section
  14. (diff | hist) 09:50 Talk:Weight regain after discontinuation 400 +150 RegainRomilly (talk | contribs) /* Lifelong treatment claim */ new section

29 January 2026

  1. (diff | hist) 22:23 Prescribing information 4,506 ±0 GIP_Genoveva (talk | contribs) de-orphan [rollback]
  2. (diff | hist) m 16:11 Dual incretin agonist 5,851 ±0 HyphenHarriet (talk | contribs) attribute the potency comparison to the head-to-head trial rather than to two separate ones [rollback]
  3. (diff | hist) 13:33 Liquid chromatography-mass spectrometry 4,463 ±0 AmylinAmos (talk | contribs) correct the flow rate — the source gives it in mL/min [rollback]
  4. (diff | hist) 13:25 Talk:Reference standard 611 +159 TFA_Counterion (talk | contribs) /* Assigned content is not purity */ reply
  5. (diff | hist) 12:00 Shanghai ERP Biotechnology 13,018 +798 Peptide_Pete (talk | contribs) expand §Ordering and availability [rollback]
  6. (diff | hist) 09:50 Talk:Reference standard 400 +201 Areapercent_Ayo (talk | contribs) /* Assigned content is not purity */ new section
  7. (diff | hist) 08:24 Multi-dose vial 24,169 +464 GramsNotUnitsGil (talk | contribs) expand §Antimicrobial preservatives [rollback]